Ken is the President and CEO of FedArb, a nationwide ADR firm based in Silicon Valley and started a decade ago by Hon. Abe Sofaer after he left the State Department. FedArb has recruited the most prestigious nationwide group of distinguished neutrals, including the largest roster of retired federal court judges in the country. FedArb’s philosophy is that distinguished neutrals who are the leaders in their fields through judicial experience or subject matter expertise are the ones who are best able to help litigants resolve complex, high stakes litigation matters.
Prior to FedArb, Mr. Hagen was the Managing Partner of Lakeside Capital, which invests in public and private companies where the resolution of some legal uncertainty is likely to be a catalyst for changes in valuation.
From 2011 to 2012, Mr. Hagen ran the San Francisco office of Bessemer Trust (a private wealth management firm that manages over $70b on behalf of ultra-high net worth clients) as its Managing Director and Senior Resident Officer. He was responsible for business development and client account management throughout Northern California and the Pacific Northwest.
Prior to Bessemer Trust, Mr. Hagen was as a senior executive at a public telecommunications company (Phone.com/Openwave) and oversaw its worldwide M&A consolidation strategy. From 1996 to 1999, he was an investment banker at Montgomery Securities and then at Robertson Stephens.
Mr. Hagen began his career at the San Francisco law firm of Pillsbury Winthrop (formerly Pillsbury Madison & Sutro) from 1983 to 1996, where he was a partner and co-headed the firm’s securities litigation practice.
Mr. Hagen holds a B.A. in Economics (President’s Fellow) from U.C. Berkeley (1980) and a J.D. from the Harvard Law School (1983). He is admitted to practice law in California and before the U.S. Supreme Court.After a close friend passed away from ALS, Mr. Hagen helped create and fund the Packard Center for ALS Research at Johns Hopkins University. He is currently a co-founder and is on the Executive Committee of the Board of the William H. Adams Foundation for ALS Research.